The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Body-mass index and diabetes risk in 57 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 685 616 adults
Open accessAbstract
Background The prevalence of overweight, obesity, and diabetes is rising rapidly in low-income and middle-income countries (LMICs), but there are scant empirical data on the association between body-mass index (BMI) and diabetes in these settings. Methods In this cross-sectional study, we pooled individual-level data from nationally representative surveys across 57 LMICs. We identified all countries in which a WHO Stepwise Approach to Surveillance (STEPS) survey had been done during a year in which the country fell into an eligible World Bank income group category. For LMICs that did not have a STEPS survey, did not have valid contact information, or declined our request for data, we did a systematic search for survey datasets. Eligible surveys were done during or after 2008; had individual-level data; were done in a low-income, lower-middle-income, or upper-middle-income country; were nationally representative; had a response rate of 50% or higher; contained a diabetes biomarker (either a blood glucose measurement or glycated haemoglobin [HbA 1c]); and contained data on height and weight. Diabetes was defined biologically as a fasting plasma glucose concentration of 7·0 mmol/L (126·0 mg/dL) or higher; a random plasma glucose concentration of 11·1 mmol/L (200·0 mg/dL) or higher; or a HbA 1c of 6·5% (48·0 mmol/mol) or higher, or by self-reported use of diabetes medication. We included individuals aged 25 years or older with complete data on diabetes status, BMI (defined as normal [18·5-22·9 kg/m 2], upper-normal [23·0-24·9 kg/m 2], overweight [25·0-29·9 kg/m 2], or obese [≥30·0 kg/m 2]), sex, and age. Countries were categorised into six geographical regions: Latin America and the Caribbean, Europe and central Asia, east, south, and southeast Asia, sub-Saharan Africa, Middle East and north Africa, and Oceania. We estimated the association between BMI and diabetes risk by multivariable Poisson regression and receiver operating curve analyses, stratified by sex and geographical region. Findings Our pooled dataset from 58 nationally representative surveys in 57 LMICs included 685 616 individuals. The overall prevalence of overweight was 27·2% (95% CI 26·6-27·8), of obesity was 21·0% (19·6-22·5), and of diabetes was 9·3% (8·4-10·2). In the pooled analysis, a higher risk of diabetes was observed at a BMI of 23 kg/m 2 or higher, with a 43% greater risk of diabetes for men and a 41% greater risk for women compared with a BMI of 18·5-22·9 kg/m 2. Diabetes risk also increased steeply in individuals aged 35-44 years and in men aged 25-34 years in sub-Saharan Africa. In the stratified analyses, there was considerable regional variability in this association. Optimal BMI thresholds for diabetes screening ranged from 23·8 kg/m 2 among men in east, south, and southeast Asia to 28·3 kg/m 2 among women in the Middle East and north Africa and in Latin America and the Caribbean. Interpretation The association between BMI and diabetes risk in LMICs is subject to substantial regional variability. Diabetes risk is greater at lower BMI thresholds and at younger ages than reflected in currently used BMI cutoffs for assessing diabetes risk. These findings offer an important insight to inform context-specific diabetes screening guidelines. Funding Harvard T H Chan School of Public Health McLennan Fund: Dean's Challenge Grant Program.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Although obesity is theoretically reversible28, 51, 52 and addressing it could provide the biggest opportunity to limit the advance of diabetes, current trends suggest that obesity rates are likely to continue to climb.45”
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Type 2 diabetes is preventable and, in some instances, reversible with early detection and adequate care.33, 45, 46”
From Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 (2024) · cites this paper as [46]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
Self-citationDiet, nutrition and the prevention of chronic diseases
Joint, W. (2002) · Medical Entomology and Zoology · Cited by 4,890
Zhou, B., Lu, Y., Hajifathalian, K., Bentham, J., Di Cesare, M., Danaei, G., Bixby, H., Cowan, M., Ali, M., Taddei, C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00618-8 · Cited by 4,311
Self-citationLevesque, R. J. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-32132-5_447-2 · Cited by 4,060
Chooi, Y. C., Ding, C., & Magkos, F. (2018) · Metabolism · doi:10.1016/j.metabol.2018.09.005 · Cited by 2,997
Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old
Adams, K. F., Schatzkin, A. G., Harris, T. B., Kipnis, V., Mouw, T., Ballard-Barbash, R. R., Hollenbeck, A. R., & Leitzmann, M. F. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055643 · Cited by 2,147
Ashwell, M., Gunn, P., & Gibson, S. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00952.x · Cited by 2,130
Ross, R., Neeland, I. J., Yamashita, S., Shai, I., Seidell, J., Magni, P., Santos, R. D., Arsenault, B., Cuevas, A., Hu, F. B., et al. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0310-7 · Cited by 1,966
Cited by
Sorted by citations
Ferrari, A. J., Santomauro, D. F., Aali, A., Abate, Y. H., Abbafati, C., Abbastabar, H., Abd ElHafeez, S., Abdelmasseh, M., Abd-Elsalam, S., Abdollahi, A., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00757-8 · Cited by 5,112
Self-citationOng, K. L., Stafford, L. K., McLaughlin, S. A., Boyko, E. J., Vollset, S. E., Smith, A. E., Dalton, B. E., Duprey, J., Cruz, J. A., Hagins, H., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01301-6 · Cited by 4,681
“28,51,52 80 These are important considerations given that in many places in the world, increases in disability due to diabetes have outpaced diabetes mortality.”
Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation
Lingvay, I., Sumithran, P., Cohen, R. V., & le Roux, C. W. (2022) · The Lancet · doi:10.1016/s0140-6736(21)01919-x · Cited by 581
Diabetes in China part 1: epidemiology and risk factors
Xu, Y., Lu, J., Li, M., Wang, T., Wang, K., Cao, Q., Ding, Y., Xiang, Y., Wang, S., Yang, Q., et al. (2024) · The Lancet Public Health · doi:10.1016/s2468-2667(24)00250-0 · Cited by 238
Wang, F., Ma, B., Ma, Q., & Liu, X. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000001071 · Cited by 175
Metadata
- Authors
- Teufel, F., Seiglie, J. A., Geldsetzer, P., Theilmann, M., Marcus, M. E., Ebert, C., Arboleda, W. A. L., Agoudavi, K., Andall-Brereton, G., Aryal, K. K., Bicaba, B. W., Brian, G., Bovet, P., Dorobantu, M., Gurung, M. S., Guwatudde, D., Houehanou, C., Houinato, D., Jorgensen, J. M. A., Kagaruki, G. B., Karki, K. B., Labadarios, D., Martins, J. S., Mayige, M. T., McClure, R. W., Mwangi, J. K., Mwalim, O., Norov, B., Crooks, S., Farzadfar, F., Moghaddam, S. S., Silver, B. K., Sturua, L., Wesseh, C. S., Stokes, A. C., Essien, U. R., De Neve, J.-W., Atun, R., Davies, J. I., Vollmer, S., Bärnighausen, T. W., Ali, M. K., Meigs, J. B., Wexler, D. J., & Manne-Goehler, J.
- Affiliations
- Heidelberg University (DE)
- Harvard University (US)
- University of Göttingen (DE)
- RWI – Leibniz Institute for Economic Research (DE)
- Togolese Ministry of Health (TG)
- Abt Associates (Nepal) (NP)
- Ministère De La Santé (BF)
- Fred Hollows Foundation (AU)
- Ministry of Health (SC)
- Ministry of Health (BT)
- Makerere University (UG)
- Université d'Abomey-Calavi (BJ)
- University of Copenhagen (DK)
- National Institute for Medical Research (TZ)
- Tribhuvan University (NP)
- Stellenbosch University (ZA)
- Costa Rican Department of Social Security (CR)
- University of Geneva (CH)
- Endocrinology and Metabolism Population Sciences Institute (IR)
- National Center for Disease Control and Public Health (GE)
- Ministry of Health and Social Welfare (LR)
- Boston University (US)
- University of Pittsburgh (US)
- University of the Witwatersrand (ZA)
- Emory University (US)
- ORCID
- Teufel, Felix
- Seiglie, Jacqueline A
- Geldsetzer, Pascal
- Theilmann, Michaela
- Marcus, Maja E
- Ebert, Cara
- Agoudavi, Kokou
- Aryal, Krishna K
- Bicaba, Brice Wilfried
- Brian, Garry
- Bovet, Pascal
- Gurung, Mongal Singh
- Guwatudde, David
- Houinato, Dismand
- Jorgensen, Jutta M Adelin
- Kagaruki, Gibson B
- Karki, Khem B
- Labadarios, Demetre
- Mayige, Mary T
- Mwalim, Omar
- Farzadfar, Farshad
- Moghaddam, Sahar Saeedi
- Sturua, Lela
- Stokes, Andrew C
- Essien, Utibe R
- Atun, Rifat
- Davies, Justine I
- Bärnighausen, Till W
- Ali, Mohammed K
- Meigs, James B
- Wexler, Deborah J
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 398
- Issue
- 10296
- Pages
- 238-248
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC8336025
- OpenAlex
- W3179285483
- Cited by
- 159
- References
- 27
- Citations by year
- 2026: 17 · 2025: 29 · 2024: 32 · 2023: 47 · 2022: 30 · 2021: 4
- FWCI
- 21.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (am, 381 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- The Lancet (acceptedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion, cc-by-nc-nd)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc-nd)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, other-oa)
- IRIS (submittedVersion)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, other-oa)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Center for Advancing Translational Sciences
- Harvard University Harvard Catalyst
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Keywords
- body mass index, diabetes risk, obesity, overweight, low- and middle-income countries, HbA1c, fasting blood glucose, diabetes prevalence, sex differences, WHO STEPS survey, health care financing, health system performance, health system resilience, health system sustainability, health system preparedness
- MeSH terms
- Adult, Cross-Sectional Studies, Developing Countries, Diabetes Mellitus, Female, Health Surveys, Glycated Hemoglobin, Humans, Male, Middle Aged, Obesity, Poverty, Global Health, Body Mass Index, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review